IPO roundup: Avrobio, Aptinyx, Magenta, Kezar, Xeris
Five biopharmas priced IPOs late on June 20, raising a total of more than $460 million. Four of the five upsized their offerings to sell more shares than anticipated; one of those, Avrobio, also priced above its proposed range.
Avrobio raised $99.7 million through the sale of 5.2 million shares at $19. The price valued